Can you lose weight on 0.25mg Wegovy — and what should you realistically expect?

Step 1: why 0.25mg exists, and what it is actually doing

Wegovy's titration schedule starts at 0.25mg for good clinical reasons. Semaglutide affects the gut as well as the brain, slowing how quickly food leaves your stomach and signalling fullness through GLP-1 receptors. Those same mechanisms can cause nausea, vomiting or diarrhoea when they kick in too quickly. The 0.25mg step is a calibration period: your system gets four weeks to adapt before the dose rises to 0.5mg, then 1.0mg, 1.7mg and eventually 2.4mg maintenance.

During this opening phase the appetite-suppressing signal is present but relatively weak. That is deliberate. Clinicians and the manufacturer's clinical team designed the schedule this way to reduce the risk of early dropout caused by severe gastrointestinal side effects. The NHS medicines information for semaglutide confirms this step-up structure, and the approach was reflected in how participants in the STEP clinical programme were managed before reaching therapeutic doses.

So if you have just started and the scales have not moved much: that is the expected picture. It does not predict how you will respond once you reach a higher dose. Patience here is genuinely part of the process, not a workaround.

Step 2: what the clinical evidence actually shows about early weight loss

The headline figures from the STEP 1 trial, published in the New England Journal of Medicine, showed an average of around 15% body-weight reduction over 68 weeks at the 2.4mg maintenance dose. That result was not spread evenly across every week of treatment. Weight loss tends to accelerate as the dose increases and plateaus or slows near the end of a trial period. The 0.25mg phase contributed very little to that overall figure.

Can you lose weight on 0.25mg Wegovy? A small number of people do, particularly those whose starting appetite is already reduced, or who make significant dietary changes at the same time. But the evidence base for Wegovy's effectiveness is built on the full titration curve, not on a single early dose. If you want to understand how results compare across the dose ladder, our page on losing weight on low-dose Wegovy looks at this in more depth.

The honest answer to 'do you lose weight on 0.25mg Wegovy' is: possibly a little, but the treatment has not really started yet.

Step 3: what to expect over the next few months as doses increase

After four weeks at 0.25mg, the standard schedule moves to 0.5mg, then 1.0mg, 1.7mg, and finally 2.4mg, each step lasting roughly four weeks, with your prescriber reviewing your progress before any increase. Some people need to stay longer at an intermediate dose if side effects are significant; others move through more smoothly. The full Wegovy dose schedule explains each step in more detail.

Appetite suppression typically becomes more noticeable as the dose rises. Many people report that the real shift in how much they want to eat comes somewhere around 1.0mg to 1.7mg. By the time you reach 2.4mg maintenance, the pharmacological effect is meaningfully stronger than at the start. This is why comparisons between early-phase experience and the trial results need careful framing: the 68-week STEP 1 figure is a cumulative outcome, not something you can expect from the opening pen alone.

If you are wondering how results look at the next rung, the 0.5mg phase tends to bring slightly more appetite change, though still below the eventual maintenance effect. And if you have been on Wegovy for a while and are curious about what higher doses deliver, see whether 1.7mg produces meaningful weight loss.

Practical points: side effects, missed doses and cost at this stage

The most commonly reported side effects at 0.25mg are mild gastrointestinal: nausea, looser stools, or some bloating. For most people these are manageable and settle within a week or two. If you miss a dose, the practical guidance on missed Wegovy doses is worth reading, do not double up, and follow the Patient Information Leaflet. Your prescriber's instructions always take precedence. The NHS semaglutide medicines page also covers what to do.

On cost: you are paying for a course of treatment, not just the starter pen. If you are at the 0.25mg stage and wondering whether the expense is worth it given limited early results, that is a fair question. Our Wegovy cost breakdown explains what the full treatment price typically reflects across the titration schedule. Timing matters here too, if you are starting in the middle of a holiday period or after a big month financially, your prescriber can discuss whether a short pause is appropriate rather than rushing ahead.

Wegovy is a prescription medicine. Every dose review happens with a clinician, not automatically, and a prescriber signs off any increase. That clinical oversight is what keeps the process safe, not just compliant.